Trials / Completed

CompletedNCT00395395

Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women

A Partially-Blind, Randomized, Single-Dose, Placebo-Controlled Crossover Phase I Study Assessing the Effect of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of SMC021 0.8 mg in Healthy Postmenopausal Women

Status: Completed
Phase: Phase 1
Study type: Interventional
Enrollment: 56 (estimated)

Sponsor: Novartis · Industry
Sex: Female
Age: 40 Years – 70 Years
Healthy volunteers: —

Summary

This is a phase I study to analyze the effect of water and food intake on the bioavailability and pharmacodynamic of oral salmon calcitonin (SMC021) and salmon calcitonin nasal spray in post-menopausal women.

Conditions

Postmenopausal Osteoporosis

Interventions

Type	Name	Description
DRUG	Oral salmon calcitonin, salmon calcitonin nasal spray

Timeline

Start date: 2006-10-01
First posted: 2006-11-02
Last updated: 2007-05-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00395395. Inclusion in this directory is not an endorsement.